FDA expands monkeypox vaccine authorization to increase dose supply five-fold

FDA expands monkeypox vaccine authorization to increase dose supply five-fold


A health worker administers a dose of the Bavarian Nordic A/S Jynneos monkeypox vaccine at a vaccination site in West Hollywood, California, on Wednesday, Aug. 3, 2022.

Jill Connelly | Bloomberg | Getty Images

The Food and Drug Administration on Tuesday expanded its authorization for the monkeypox vaccine in a way that would significantly boost the limited supply of shots.

The FDA will allow health-care providers to administer the shots through intradermal injection, or between the layers of the skin, which will increase the supply of doses by as much as fivefold. The vaccine is traditionally administered through subcutaneous injection, which goes into the fat layer beneath the skin. The intradermal injections are only for adults.

The emergency authorization also allows people under age 18 to receive the vaccine if they are at high risk of monkeypox infection. People under age 18 would receive the shot through subcutaneous injection.

Jynneos is the only FDA approved monkeypox vaccine in the U.S. The shots are administered in two doses 28 days apart. Jynneos is manufactured by Bavarian Nordic, a biotech company based in Denmark.

The U.S. has struggled to keep with up demand for the shots as the monkeypox outbreak grows, which has made it difficult for people to get appointments and lead to long lines outside clinics.

The U.S. is fighting the largest monkeypox outbreak in the world with nearly 9,000 cases across 49 states, Washington D.C. and Puerto Rico, according to the Centers for Disease Control and Prevention.

Health and Human Services Secretary Xavier Becerra declared the outbreak a public health emergency last week. The U.S. last declared a public health emergency in response to Covid-19 in 2020.

HHS has made more than 1 million doses available to state and local health departments since May. More than 620,000 doses have been shipped to jurisdictions so far, according to HHS.

This is breaking news. Please check back for updates.

CNBC Health & Science

Read CNBC’s latest global health coverage:



Source

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days
Health

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days

U.S. President Donald Trump, U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, David Sacks, AI & Crypto Czar and Amy Gleason, Acting Administrator, Department of Government Efficiency (DOGE) attend the “Making Health Technology Great Again” event in the East Room […]

Read More
Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity
Health

Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity

Mounjaro manufactured by Eli Lilly and Company packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on April 9, 2024. Nurphoto | Nurphoto | Getty Images Eli Lilly on Thursday said its blockbuster diabetes drug Mounjaro showed heart health benefits in a late-stage trial directly comparing it to the company’s […]

Read More
Pandemic darlings Moderna, BioNTech are now on two different paths
Health

Pandemic darlings Moderna, BioNTech are now on two different paths

A researcher works in the lab at the Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024.  Adam Glanzman | Bloomberg | Getty Images The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies are on different paths. Both Moderna and BioNTech helped pioneer mRNA, or […]

Read More